Info on Regeneron that POTUS was given for his covid treatment

page 21

A guide to Home-Based COVID Treatment

Step by Step Doctors' that could save your life

(nice guide, updated Feb 1, 2021)

Monoclonal antibodies

Natural Antibodies are produced by the body in response to foreign organisms, such as viruses and bacteria. Synthetic antibodies are those produced in a laboratory to mimic ones the body can make. When these synthetic compounds, referred to as “monoclonal antibodies,” are made in the lab targeted for a new treatment in medicine, they are patented as new therapeutic agents. This is the type of experimental synthetic monoclonal antibody, Regeneron, you heard described on the news that was given to President Trump as part of his treatment for COVID-19 when he was in the hospital at Walter Reed.

The company Regeneron has produced a drug, called REGN-COV2, that is a combination of two “monoclonal antibodies” intended to fight off the virus SARS-CoV-2 that causes the illness we call CoVID-19. To develop REGN-COV2, Regeneron scientists use antibodies from mice that have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID19.

The overall effectiveness of Regeneron as a new treatment remains to be seen, since it is still in the experimental stage and is undergoing clinical trials. Only after randomized, controlled clinical trials are completed, will we be able to analyze the clinical data and submit it to the peer-review process needed to determine its overall safety and effectiveness, as well as its side-effect profile.

https://media.8kun.top/file_store/48970a73677a5e2eccbc8b69a015a91b2ad9db7ded5850563d64c1b96dbec325.pdf

h/t to op

https://8kun.top/qresearch/res/13559852.html#13560204